Independent health-product research & buyer guidance. We may earn a commission from purchases through our links. Details
✦BoostaroProduct Research Hub
Boostaro • Independent Research

Boostaro Ingredients: Seven Named Actives & Label Limits

All seven named nutrients, aminos, botanical compounds and enzymes explained with label questions.

Seven ingredients named by Boostaro

The official long-form sales story identifies L-citrulline, pine bark extract, vitamin C, L-lysine, magnesium, vitamin K2 and nattokinase. Each has a different biological role, and they should not be presented as collectively proven to treat erectile dysfunction.

A secondary brand-labelled Supplement Facts panel shows a 725 mg proprietary blend in which five actives have no separately disclosed doses.

Vitamin C

An antioxidant essential for normal collagen production; the sales copy links it to blood-vessel support.

Reported dose: 500 mg on one publicly available Boostaro Supplement Facts panel

Ingredient evidence and safety →

Vitamin K (Menaquinone)

Vitamin K participates in blood clotting and normal physiology. The seller connects K2 to blood-vessel health.

Reported dose: 100 mcg on a publicly available Boostaro Supplement Facts panel

Ingredient evidence and safety →

L-Citrulline

L-citrulline participates in arginine and nitric-oxide pathways; some research examines vascular function.

Reported dose: Individual amount undisclosed within a reported 725 mg proprietary blend

Ingredient evidence and safety →

L-Lysine HCl

Lysine is an essential amino acid used in protein metabolism and collagen-associated physiological processes.

Reported dose: Individual amount undisclosed within a reported 725 mg proprietary blend

Ingredient evidence and safety →

Maritime Pine Bark Extract

Pine bark contains proanthocyanidins, phytochemicals examined for vascular and antioxidant activity.

Reported dose: Individual amount undisclosed within a reported 725 mg proprietary blend

Ingredient evidence and safety →

Magnesium Citrate

Magnesium is important for normal muscle and nerve function and many enzymatic processes.

Reported dose: Individual amount undisclosed within a reported 725 mg proprietary blend

Ingredient evidence and safety →

Nattokinase

Nattokinase is an enzyme associated with fermented soy food and studied for circulation-related outcomes.

Reported dose: Individual amount and enzyme activity undisclosed within a reported 725 mg proprietary blend

Ingredient evidence and safety →

What is in Boostaro

The original seller story lists L-citrulline, maritime pine bark extract, vitamin C, L-lysine, magnesium, vitamin K2 and nattokinase.

These components span amino acids, vitamins, a mineral, a botanical extract and an enzyme; they do not all have the same evidence base or safety profile.

Amount disclosure

A separate seller-branded page reports 500 mg vitamin C and 100 mcg vitamin K alongside a 725 mg proprietary formula.

The five other ingredients share that blend amount, so claims about the dose of any single blend ingredient would be speculative.

Why the blend matters

Dose, plant extract standardization, manufacturing and individual medicine interactions matter when comparing products.

Clinical studies of individual ingredients at known doses cannot be assumed to demonstrate benefits from unspecified quantities in a blended formula.

Ingredient decisions

A complete physical bottle label can help pharmacists check intended use, excipients and potential interactions.

Pay particular attention to the clotting-related cautions for nattokinase and vitamin K if taking medications.

Common buyer questions for this topic

The most reliable product-specific answer starts with the current physical label and final merchant terms, followed by appropriate medical advice about medicines and pre-existing conditions.

Discounted bundle pricing, positive promotional testimonials and ingredient-level citations cannot by themselves establish a medical treatment outcome.

More Boostaro buyer research

Sources and editorial verification

We checked the user-provided official sales campaign on November 9, 2026. Where amounts come from a separate Boostaro-branded label page, that source is identified explicitly. Ingredient or disease research is not an endorsement of Boostaro.

  1. Boostaro official /long/ sales campaign, checked November 9, 2026
  2. Seller-branded Boostaro ingredient-label presentation (secondary comparison)
  3. NIDDK: Erectile Dysfunction overview
  4. Memorial Sloan Kettering: Nattokinase safety
  5. NIH Office of Dietary Supplements: Vitamin K
  6. FDA: Dietary supplement information for consumers
Check Current Boostaro Offer We may earn a commission.